CCOI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CCOI is not a good buy right now for a Beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading weakly, fundamentals are deteriorating, analysts have been cutting targets, and insiders are selling. While the options market is strongly bullish and there is a near-term earnings date that could create a catalyst, the overall setup is better suited to a more tactical trader than a long-term beginner. My direct view: hold off on buying now.
Technically, CCOI is under pressure but not in a full breakdown. The stock closed at 22.66, just above S1 at 22.439 and below the pivot at 23.673, which keeps the short-term trend cautious. RSI_6 at 38.835 is neutral-to-weak, MACD histogram is slightly positive but contracting, and moving averages are converging, suggesting a lack of strong momentum. The recent pattern also points to limited upside near term, with only modest one-week and one-month expected gains from pattern analysis.
Upcoming QMAR 2026 earnings on 2026-05-04 Pre-Market could serve as a catalyst. Gross margin improved sharply year over year in the latest quarter, and there is some support from the ongoing possibility of balance-sheet related actions such as datacenter sales or refinancing mentioned by analysts. The options market is also heavily call-skewed, reflecting bullish near-term sentiment.
No news in the recent week, so there is no fresh positive headline momentum. Revenue fell 4.66% YoY in Q4 2025, net income remained negative and worsened, and EPS declined further. Analysts have broadly lowered price targets across RBC, Wells Fargo, Oppenheimer, TD Cowen, KeyBanc, Citi, UBS, and Goldman Sachs, with several citing weak results and murky forward outlook. Insiders are selling, and the selling amount increased sharply over the last month.
In 2025/Q4, revenue dropped to $240.5M, down 4.66% YoY. Net income fell to -$30.8M, and EPS dropped to -$0.64, both worsening year over year. The only clear positive was gross margin, which increased to 22.34%, showing some operational improvement, but overall the latest quarter was weak and did not show durable growth momentum.
Analyst sentiment has turned more cautious over the last several weeks, with multiple firms cutting price targets. RBC lowered target to $22 and kept Sector Perform, Wells Fargo cut to $23 with Equal Weight, Citi to $22 Neutral, UBS to $21 Neutral, Goldman to $22 Neutral, while Oppenheimer, TD Cowen, and KeyBanc remained more constructive but still reduced targets significantly. Wall Street’s pros view is that CCOI may have some asset/balance-sheet catalysts and could be oversold, but the cons view is dominant: revenue decay, weak quarter results, uncertain execution, and limited visibility.
